Cardiology
他汀类药物在CHIP-ASCVD研究中的应用
Statin Use in CHIP–ASCVD ResearchThe investigation into the role of statins in the context of Cardiovascular Health in Patients with Cancer (CHIP) and Atherosclerotic Cardiovascular Disease (ASCVD), examining potential biases and biological mechanisms. / 针对心血管健康与癌症患者（CHIP）及动脉粥样硬化性心血管疾病（ASCVD）背景下他汀类药物作用的研究，探讨潜在偏倚与生物学机制。
- Knowledge type
- 实际应用
- First proposed or discovered
- Proposer
- Turkey Farm member
- Creator
- 农场主
- Last updated
- 2026-11-14 18:06:07
Sub-knowledge points
StatinsCardiovascular Health in Patients with Cancer (CHIP)Atherosclerotic Cardiovascular Disease (ASCVD)Bias in clinical researchBiology of statins
Higher-order knowledge points
Cardio-OncologyCardiovascular diseaseCancer treatmentClinical trials
Main parameters and performance indicators
CHIP: Cardiovascular Health in Patients with CancerASCVD: Atherosclerotic Cardiovascular DiseaseStatin: HMG-CoA reductase inhibitor
Open problems
Distinguishing between statistical bias and true biological effectsDetermining the optimal statin regimen for cancer patients with cardiovascular risk
Related literature
ranked by community starsStatin Use in CHIP–ASCVD Research: Bias, Biology, or Both?Open source
Related products and links
No item recorded yet
Creation and modification trail
1 recordsRecord title: Statin Use in CHIP–ASCVD Research.
Node update feedback
review required